Aims: To evaluate the prevalence of osteoporosis during inflammatory bowel disease (IBD) and to determine the risk factors.
Methods: We conducted a prospective study that includes IBD patients. For all patients, bone mineral density was measured by dual-energy X-rays absorptiometry.